Evidence map›Paper›PMID 40858240›Full record

ArticleCancer letters2025

Protective role of epithelial deoxyhypusine synthase in colorectal carcinogenesis caused by deletion of the adenomatous polyposis coli gene.

Alain P Gobert, Caroline V Hawkins, Lydia A Snyder, Kamery J Williams, Daniel P Barry, Margaret M Allaman, Mohammad Asim, Kara M McNamara, Shane M Carey, Alberto G Delgado and 10 more

Abstract read
In one paragraph

Article in Cancer letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alain P GobertDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Center for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address: alain.p.gobert@vumc.org.
Caroline V HawkinsDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Lydia A SnyderDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Kamery J WilliamsDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Daniel P BarryDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Margaret M AllamanDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Mohammad AsimDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Kara M McNamaraDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Shane M CareyDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Alberto G DelgadoDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Regina N TyreeDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Kristie L RoseDepartment of Biochemistry, Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Yu WangDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Shilin ZhaoDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Olivier BoutaudWarren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Irène Zagol-IkapitteWarren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
M Blanca PiazueloDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Center for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
M Kay WashingtonCenter for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Lori A CoburnDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Center for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, 37232, USA.
Keith T WilsonDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Center for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, 37232, USA. Electronic address: keith.wilson@vumc.org.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TIMOTHY L COVER · 2009 to 2026
$27.5M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
Tennessee Valley Cooperative Human Tissue NetworkUM1CA183727 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2014 to 2026
$12.6M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated CarcinogenesisR01DK128200 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2021 to 2024
$2.7M
Polyamine Dysregulation in the Gastric Epithelium during Helicobacter pylori Infection and its Impact on Gastric CarcinogenesisF31CA278330 · NCI · VANDERBILT UNIVERSITY · PI MCNAMARA, KARA · 2023 to 2025
$72k
BLRD VA I01 BX004366CSRD VA I01 CX002171CSRD VA I01 CX002473CSRD VA I01 CX002662NCI NIH HHS F31 CA278330NCI NIH HHS P01 CA116087NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA236733NCI NIH HHS T32 CA009592NCI NIH HHS UM1 CA183727NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK128200
6 · The paper itself

Abstract

Mutations in the adenomatous polyposis coli (APC) gene lead to the formation of adenomatous polyps in the colon that can evolve into carcinoma. We have reported that deoxyhypusine synthase (DHPS), the rate-limiting enzyme for the synthesis of the amino acid hypusine on the eukaryotic translation initiation factor 5A, plays a major role in intestinal homoeostasis. Here, we investigated the role of hypusination in sporadic colorectal cancer (CRC). GEO database analyses revealed increases in polyamine metabolism genes, including DHPS, in human CRC. Tumors exhibited increased immunostaining for DHPS compared non-tumor tissues. Then, we generated mice with tamoxifen-inducible disruption of both Apc and Dhps in intestinal epithelial cells. Compared to animals with deletion of Apc only, survival and body weight loss were worsened in mice with specific deletion of both Apc and Dhps. Moreover, these animals had increased tumor number, tumor burden, and adenomas with low-grade or high-grade dysplasia. Differential label-free quantitative proteomic analysis on colonic epithelial cells demonstrated that DHPS activity in the tumors supported the translation of enzymes implicated in detoxification of deleterious electrophiles. Thus, tumors from mice with Apc and Dhps deletion exhibited increased malondialdehyde-dilysyl crosslinks. Further, the exacerbated tumorigenesis in mice with deletion of Apc and Dhps was significantly reduced by treatment with a scavenger of electrophiles, 2-hydroxybenzylamine. Thus, epithelial hypusination is essential to dampen the initiation of adenoma formation, notably by reducing the deleterious effects of reactive aldehydes. Strategies to enhance hypusination, such as by spermidine supplementation, may have potential for chemoprevention of CRC.

Indexed as

Adenomatous Polyposis Coli ProteinColorectal NeoplasmsGenes, APCOxidoreductases Acting on CH-NH Group DonorsAnimalsCarcinogenesisEpithelial CellsGene DeletionHumansLysineMiceMice, KnockoutAdenomatous Polyposis Coli Proteindeoxyhypusine synthasehypusineLysineOxidoreductases Acting on CH-NH Group DonorsCarcinogenesisColonColorectal cancerDeoxyhypusine synthaseHypusinePolyamineReactive aldehyde

Identifiers

PMID40858240
PMCPMC12696740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.